Wayne Allyn Root Promotes Pre-IPO Medical Biotech Investment
A $10,000 minimum investment for 2,000 shares at $5 per share is currently available for Regenerative Medicine of Europe, according to CEO Dan Meto, who detailed the firm's work on treatments for Parkinson's, type 2 diabetes, heart disease, and chronic pain.
The current offering is for a sister company, Regenerative Medicine of Europe, requiring a minimum investment of $10,000 for 2,000 shares at $5 per share, with an anticipated IPO in 9 to 12 months, projecting share prices between $10 and $15.


